The recent joint inquiry by the Federal Trade Commission (FTC), the Department of Justice (DOJ), and the U.S. Department of Health and Human Services (HHS) into corporate control in healthcare demands our attention as members of NATSAP. This inquiry aims to scrutinize transactions involving private equity and corporate ownership in the healthcare sector, assessing their impact on patient care, workers' safety, quality of care, and affordability.

As advocates for high-quality therapeutic education and programs, NATSAP recognizes the importance of maintaining rigorous standards of care amidst increasing corporate involvement in healthcare. We are committed to staying informed about regulatory developments and advocating for the best interests of our members and the individuals they serve.

Moving forward, NATSAP will continue to monitor the progress of this inquiry and provide updates to our members as necessary. We encourage all members to stay informed and engaged in discussions surrounding this inquiry, as its findings could have significant implications for the therapeutic education and programs industry.